Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariates

Pocock, 1976, The combination of randomized and historical controls in clinical trials, J. Chronic Dis., 29, 175, 10.1016/0021-9681(76)90044-8 Lim, 2020, Reducing patient burden in clinical trials through the use of historical controls: appropriate selection of historical data to minimize risk of bias, Ther. Innov. Regul. Sci., 54, 850, 10.1007/s43441-019-00014-4 Rosenbaum, 1983, The central role of the propensity score in observational studies for causal effects, Biometrika, 70, 41, 10.1093/biomet/70.1.41 Wang, 2019, Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies, J. Biopharm. Stat., 29, 731, 10.1080/10543406.2019.1657133 Chen, 2020, Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data, J. Biopharm. Stat., 30, 508, 10.1080/10543406.2020.1730877 Wang, 2020, Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies, J. Biopharm. Stat., 30, 495, 10.1080/10543406.2019.1684309 Yuan, 2019, Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls, J. Biopharm. Stat., 29, 558, 10.1080/10543406.2018.1559853 Lin, 2018, Propensity score matched augmented controls in randomized clinical trials: a case study, Pharm. Stat., 17, 629 Xu, 2020, A study design for augmenting the control group in a randomized controlled trial: a quality process for interaction among stakeholders, Ther. Innov. Regul. Sci., 54, 269, 10.1007/s43441-019-00053-x Lin, 2021, Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies, J. Biopharm. Stat., 1 Liu, 2021, Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data, Stat. Med, 40, 4794, 10.1002/sim.9095 Neuenschwander, 2010, Summarizing historical information on controls in clinical trials, Clin. Trials, 7, 5, 10.1177/1740774509356002 Ibrahim, 2000, Power prior distributions for regression models, Stat. Sci., 46 Duan, 2006, Evaluating water quality using power priors to incorporate historical information, Environmetrics, 17, 95, 10.1002/env.752 Neuenschwander, 2009, A note on the power prior, Stat. Med., 28, 3562, 10.1002/sim.3722 Hobbs, 2011, Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials, Biometrics, 67, 1047, 10.1111/j.1541-0420.2011.01564.x Han, 2017, Covariate-adjusted borrowing of historical control data in randomized clinical trials, Pharm. Stat., 16, 296, 10.1002/pst.1815 Fu, 2023, Covariate handling approaches in combination with dynamic borrowing for hybrid control studies, Pharm. Stat., 22, 585, 10.1002/pst.2297 Pirracchio, 2015, Improving propensity score estimators’ robustness to model misspecification using super learner, Am. J. Epidemiol., 181, 108, 10.1093/aje/kwu253 Lee, 2010, Improving propensity score weighting using machine learning, Stat. Med., 29, 337, 10.1002/sim.3782 Austin, 2011, An introduction to propensity score methods for reducing the effects of confounding in observational studies, Multivar. Behav. Res., 46, 399, 10.1080/00273171.2011.568786 Rosenbaum, 1987, Model-based direct adjustment, J. Am. Stat. Assoc., 82, 387, 10.1080/01621459.1987.10478441 Lunceford, 2004, Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study, Stat. Med., 23, 2937, 10.1002/sim.1903 McCandless, 2009, Bayesian propensity score analysis for observational data, Stat. Med., 28, 94, 10.1002/sim.3460 Spanakis, 2022, Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing, J. Biopharm. Stat., 1, 10.1080/10543406.2022.2152833 Lin, 2022, Matching within a hybrid RCT/RWD: framework on associated causal estimands, J. Biopharm. Stat., 1, 10.1080/10543406.2022.2036992 Inman, 1989, The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities, Commun. Stat. Theor. Methods, 18, 3851, 10.1080/03610928908830127 Schmidli, 2014, Robust meta-analytic-predictive priors in clinical trials with historical control information, Biometrics, 70, 1023, 10.1111/biom.12242